Malaysia MDA Strengthens Oversight of Medical Device Procurement Supply Chain

On January 28, 2026, the Medical Device Authority (MDA) implemented “Circular Letter No. 1/2026”, establishing updated regulatory requirements governing medical device procurement by healthcare facility institutions in Malaysia under the Medical Device Act 2012 (Act 737). The policy was approved during MDA Authority Meeting No. 1/2026.

The circular formalizes how procurement activities — including public and private medical device tenders — are implemented and enforced under Malaysia’s medical device regulatory framework. With its issuance, the MDA has also revoked “Circular Letter No. 2/2016 (Revision 2)”, replacing the previous guidance governing procurement practices.

The updated guidance reinforces regulatory expectations for companies participating in medical device procurement tenders and confirms that only licensed establishments meeting regulatory requirements may supply regulated medical devices through these procurement activities. For support with compliance for Malaysian medical device tenders, contact Cisema today.

Tender Participation Classified as “Placing in the Market”

Under Circular Letter No. 1/2026, the supply of medical devices through procurement tenders is explicitly defined as “placing in the market.”

As a result, any company or supplier representative that participates in and successfully secures a medical device procurement tender — referred to as the tenderer — is considered an establishment under Section 2 of the Medical Device Act 2012.

This classification means that tenderers are subject to the regulatory obligations established under Malaysia’s medical device regulatory framework, including licensing and distribution compliance requirements.

For manufacturers supplying devices into Malaysia through procurement channels, this clarification highlights the importance of ensuring that distribution activities are conducted through properly licensed establishments, such as authorized representatives (like Cisema) or local distributors.

Mandatory Regulatory Requirements for Tenderers

Companies that successfully secure procurement tenders must meet the regulatory obligations established under Section 15(1) of the Medical Device Act 2012.

These requirements ensure that companies participating in procurement activities operate in accordance with Malaysia’s regulatory framework for medical device distribution and post-market oversight.

Establishment Licensing Requirements

Tenderers must hold a valid establishment license authorizing them to conduct medical device distribution activities in Malaysia. Without this license, companies cannot legally supply devices through procurement channels.

Quality Management System Requirements

Tenderers must implement and maintain a Quality Management System (QMS) aligned with Good Distribution Practice for Medical Devices (GDPMD). This system ensures that distribution activities follow recognized regulatory and quality standards.

Post-Market Responsibilities

Tenderers also assume ongoing post-market obligations once devices enter the Malaysian market. These responsibilities include:

• Medical device incident reporting to the MDA
• Complaint handling and investigation
• Implementation of field safety corrective actions when required
• Execution of product recalls where necessary

Procurement Compliance Obligations for Healthcare Facilities

The circular also establishes due diligence requirements for healthcare institutions involved in medical device procurement.

Both public and private healthcare facilities must obtain regulatory documentation from the tenderer before finalizing procurement decisions.

Required Documentation Before Procurement Approval

Healthcare institutions must obtain the following documents from the tenderer prior to completing procurement:

• A copy of the establishment license issued to the tenderer as a medical device distributor
• A valid medical device registration certificate for the device being procured
• A letter of appointment as distributor issued by the Authorized Representative (AR) or original establishment

Documentation Traceability Requirements

The circular also introduces traceability requirements for procurement documentation.

All procurement-related documents — including quotations, invoices, delivery orders, and commissioning documentation — must clearly identify the licensed establishment responsible for distribution.

This requirement is intended to improve traceability and regulatory accountability throughout procurement transactions.

Regulatory Implications for Medical Device Suppliers

For foreign manufacturers and distributors supplying devices to Malaysia, companies participating in procurement tenders must ensure:

• Distribution activities are conducted through a licensed establishment
• Devices supplied through procurement hold valid Malaysian registration
• Healthcare institutions can verify supplier compliance documentation
• Distribution activities comply with GDPMD quality system requirements

These measures strengthen accountability across the supply chain while supporting patient safety and regulatory transparency.

Strengthening Compliance in Malaysia’s Medical Device Procurement System

Malaysia’s latest procurement circular reflects a broader regulatory shift toward tighter oversight of the medical device supply chain. By explicitly linking procurement tender participation to regulatory licensing requirements, the MDA has reinforced accountability for companies supplying medical devices to healthcare institutions.

For international manufacturers, however, procurement compliance often requires aligning multiple regulatory elements, such as medical device registration in Malaysia, Authorized Representative arrangements, distributor licensing, and GDPMD-compliant quality systems. Misalignment between these elements can delay tender eligibility, limit procurement participation, or create regulatory risk.

Cisema supports global medical device manufacturers through these complexities, providing regulatory strategy, Authorized Representative services, and market entry compliance across Southeast Asia. Our team helps companies establish compliant distribution structures, maintain establishment licensing, and manage medical device registrations required for participation in Malaysian procurement programs.

Contact Cisema to ensure your medical device registration and distribution strategy fully aligns with Malaysia’s procurement and regulatory requirements.

Further Information

For details about regulatory support services in Malaysia, visit Cisema’s Medical Device Regulatory Services in Malaysia.

References

• Medical Device Authority (MDA) — “Circular Letter No. 1/2026: Medical Device Procurement for Healthcare Facility Institutions”
• Medical Device Authority (MDA) — “Medical Device Act 2012 (Act 737) (English)”